Genomic changes detected after serial passages in cell culture of virulent human G1P[8] rotaviruses

Angel, 1998, Studies of the role for NSP4 in the pathogenesis of homologous murine rotavirus diarrhea, J. Infect. Dis., 177, 455, 10.1086/517374 Angel, 2012, Rotavirus immune responses and correlates of protection, Curr. Opin. Virol., 2, 419, 10.1016/j.coviro.2012.05.003 Arora, 2011, Sequence analysis of VP4 genes of wild type and culture adapted human rotavirus G1P[8] strains, Asian Pac J Trop Med, 4, 541, 10.1016/S1995-7645(11)60142-9 Bagchi, 2013, Rotavirus NSP1 inhibits interferon induced non-canonical NFκB activation by interacting with TNF receptor associated factor 2, Virology, 444, 41, 10.1016/j.virol.2013.07.003 Barro, 2007, Rotavirus NSP1 inhibits expression of type I interferon by antagonizing the function of interferon regulatory factors IRF3, IRF5, and IRF7, J. Virol., 81, 4473, 10.1128/JVI.02498-06 Bernstein, 1999, Efficacy of live, attenuated, human rotavirus vaccine 89-12 in infants: a randomized placebo-controlled trial, Lancet, 354, 287, 10.1016/S0140-6736(98)12106-2 Chang, 1999, Comparisons of nucleotide and deduced amino acid sequences of NSP4 genes of virulent and attenuated pairs of group A and C rotaviruses, Virus Genes, 18, 229, 10.1023/A:1008068218966 Esona, 2010, Molecular characterization of human rotavirus vaccine strain CDC-9 during sequential passages in Vero cells, Hum. Vaccin., 6, 247, 10.4161/hv.6.3.10409 Estes, 2001, Rotaviruses and their replication, 1747 Estes, 2013, Rotaviruses, 1347 Hanley, 2011, The double-edged sword: how evolution can make or break a live-attenuated virus vaccine, Evolution, 4, 635 Hoshino, 1995, Identification of group A rotavirus genes associated with virulence of a porcine rotavirus and host range restriction of a human rotavirus in the gnotobiotic piglet model, Virology, 209, 274, 10.1006/viro.1995.1255 Hundley, 1985, Genome rearrangements of bovine rotavirus after serial passage at high multiplicity of infection, Virology, 143, 88, 10.1016/0042-6822(85)90099-6 Kapikian, 2001, Rotaviruses, 1787 Kearney, 2004, Cell-line-induced mutation of the rotavirus genome alters expression of an IRF3-interacting protein, EMBO J., 23, 4072, 10.1038/sj.emboj.7600408 Kitamoto, 1993, Alterations in the sequence of the gene 4 from a human rotavirus after multiple passages in HepG2 liver cells, Arch. Virol., 130, 179, 10.1007/BF01319006 Komoto, 2013, Genetic engineering of rotaviruses by reverse genetics, Microbiol. Immunol., 57, 479 Komoto, 2006, Reverse genetics system for introduction of site-specific mutations into the double-stranded RNA genome of infectious rotavirus, Proc. Natl. Acad. Sci. U. S. A., 103, 4646, 10.1073/pnas.0509385103 López, 2004, Multistep entry of rotavirus into cells: a Versaillesque dance, Trends Microbiol., 12, 271, 10.1016/j.tim.2004.04.003 Maan, 2007, Rapid cDNA synthesis and sequencing techniques for the genetic study of bluetongue and other dsRNA viruses, J. Virol. Methods, 143, 132, 10.1016/j.jviromet.2007.02.016 Matthijnssens, 2008, Full genome-based classification of rotaviruses reveals common origin between human Wa-like and porcine rotavirus strains and human DS-1-like and bovine rotavirus strains, J. Virol., 82, 3204, 10.1128/JVI.02257-07 Matthijnssens, 2012, VP6-sequence-based cutoff values as a criterion for rotavirus species demarcation, Arch. Virol., 157, 1177, 10.1007/s00705-012-1273-3 Mihalov-Kovás, 2015, Candidate new rotavirus species in sheltered dogs, Hungary, Emerg. Infect. Dis., 21, 660, 10.3201/eid2104.141370 Mohan, 2000, Comparative sequence analysis identified mutations outside the NSP4 cytotoxic domain of tissue culture-adapted ATCC-Wa strain of human rotavirus and a novel inter-species variable domain in its C-terminus, Arch. Virol., 145, 1789, 10.1007/s007050070056 Richards, 2013, Experimental pathways towards developing a rotavirus reverse genetics system: synthetic full length rotavirus ssRNAs are neither infectious nor translated in permissive cells, PLoS One, 8, 10.1371/journal.pone.0074328 Ruiz-Palacios, 2006, Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis, N. Engl. J. Med., 354, 11, 10.1056/NEJMoa052434 Tate, 2012, 2008 estimate of worldwide rotavirus-associated mortality in children younger than 5years before the introduction of universal rotavirus vaccination programmes: a systematic review and meta-analysis, Lancet Infect. Dis., 12, 136, 10.1016/S1473-3099(11)70253-5 Trask, 2010, Dual selection mechanisms drive efficient single-gene reverse genetics for rotavirus, Proc. Natl. Acad. Sci. U. S. A., 107, 18652, 10.1073/pnas.1011948107 Troupin, 2010, Rearranged genomic RNA segments offer a new approach to the reverse genetics of rotaviruses, J. Virol., 84, 6711, 10.1128/JVI.00547-10 Tsugawa, 2008, Whole genome sequence and phylogenetic analyses reveal human rotavirus G3P[3] strains Ro1845 and HCR3A are examples of direct virion transmission of canine/feline rotaviruses to humans, Virology, 380, 344, 10.1016/j.virol.2008.07.041 Tsugawa, 2014, Virulence-associated genome mutations of murine rotavirus identified by alternating serial passages in mice and cell cultures, J. Virol., 88, 5543, 10.1128/JVI.00041-14 Vesikari, 2006, Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine, N. Engl. J. Med., 354, 23, 10.1056/NEJMoa052664 Ward, 1997, Attenuation of a human rotavirus vaccine candidate did not correlate with mutations in the NSP4 protein gene, J. Virol., 71, 6267, 10.1128/JVI.71.8.6267-6270.1997 Ward, 2006, Reductions in cross-neutralizing antibody responses in infants after attenuation of the human rotavirus vaccine candidate 89-12, J. Infect. Dis., 194, 1729, 10.1086/509623 Wyatt, 1980, Human rotavirus type 2: cultivation in vitro, Science, 207, 189, 10.1126/science.6243190 Yuan, 1996, Systemic and intestinal antibody-secreting cell responses and correlates of protective immunity to human rotavirus in a gnotobiotic pig model of disease, J. Virol., 70, 3075, 10.1128/JVI.70.5.3075-3083.1996 Zhang, 1998, Mutations in rotavirus nonstructural glycoprotein NSP4 are associated with altered virus virulence, J. Virol., 72, 3666, 10.1128/JVI.72.5.3666-3672.1998